Skip to main content
Advertisement
Advertisement
PRCT
PRCT logo
PROCEPT BioRobotics Corporation Common Stock
20.03
USD
Sponsored
+1.76
+9.63%
Oct 22, 15:59 UTC -4
Closed
exchange

After-Market

19.68

-0.35
-1.75%

PROCEPT BioRobotics Corporation Common Stock (PRCT) Earnings

PRCT Earnings Reports

Positive Surprise Ratio

PRCT beat 11 of 20 last estimates.

55%

Next Report

Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$104.61M
/
-$0.39
Implied change from Q2 26 (Revenue/ EPS)
+10.71%
/
-17.02%
Implied change from Q3 25 (Revenue/ EPS)
+25.55%
/
+2.63%

PROCEPT BioRobotics Corporation Common Stock earnings per share and revenue

On Aug 04, 2026, PRCT reported earnings of -0.47 USD per share (EPS) for Q2 26, missing the estimate of -0.46 USD, resulting in a -0.84% surprise. Revenue reached 94.50 million, compared to an expected 94.75 million, with a -0.27% difference. The market reacted with a +5.80% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 14 analysts forecast an EPS of -0.39 USD, with revenue projected to reach 104.61 million USD, implying an decrease of -17.02% EPS, and increase of 10.71% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Integra LifeSciences Holdings
Report Date
Oct 21, 2026 For Q3 26
Estimate
$0.57
Actual
$0.59
Surprise
+3.04%
logo
AngioDynamics, Inc.
Report Date
Oct 08, 2026 For Q1 27
Estimate
-$0.11
Actual
-$0.04
Surprise
+65.40%
logo
Thermo Fisher Scientific, Inc.
Report Date
Oct 21, 2026 For Q3 26
Estimate
$6.46
Actual
$6.68
Surprise
+3.29%
logo
Intuitive Surgical Inc.
Report Date
Oct 20, 2026 For Q3 26
Estimate
$2.69
Actual
$3.00
Surprise
+11.30%
FAQ
For Q2 2026, PROCEPT BioRobotics Corporation Common Stock reported EPS of -$0.47, missing estimates by -0.84%, and revenue of $94.50M, -0.27% below expectations.
The stock price moved up 5.8%, changed from $18.28 before the earnings release to $19.34 the day after.
The next earning report is scheduled for Nov 04, 2026.
Based on 14 analysts, PROCEPT BioRobotics Corporation Common Stock is expected to report EPS of -$0.39 and revenue of $104.61M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement